Skip to main content
Erschienen in: Indian Journal of Gastroenterology 6/2011

01.12.2011 | Original Article

Effect of bovine colostrum-based food supplement in the treatment of HIV-associated diarrhea in Northern Uganda: a randomized controlled trial

verfasst von: F. O. Kaducu, S. A. Okia, G. Upenytho, L. Elfstrand, C.-H. Florén

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Aim

HIV-associated diarrhea is common in HIV/AIDS patients in developing countries. An earlier uncontrolled study showed that a nutritional product made from bovine colostrum (ColoPlus®) alleviates HIV-associated diarrhea. We performed a randomized single-blind controlled trial of addition of colostrum-based supplement (ColoPlus®) to standard anti-diarrhea treatment in HIV/AIDS patients with diarrhea.

Methods

Eighty-seven adult patients with HIV-associated diarrhea were recruited at Gulu Hospital and four community clinics in Northern Uganda. Forty-five patients were randomized to receive 50 g of colostrum-based supplement twice a day for 4 weeks in addition to standard anti-diarrhea treatment, and 42 patients received standard anti-diarrhea treatment alone. Patients were followed up for 9 weeks. Daily stool frequency was recorded, and body weight and body mass index were evaluated at weeks 1, 4 and 9. Baseline CD4+ count was measured at baseline and at week 9.

Results

Mean daily stool frequency decreased by 79% from 7.5 to 1.3 motions over the study period in patients on colostrum-based supplement, compared to a 58% reduction in controls (p < 0.001). Self-reported fatigue was reduced by 85% in patients on colostrum-based supplement by week 9 compared to 43% reduction amongst controls (p < 0.001). Patients on colostrum-based supplement had 11% increase (p < 0,001) in mean body weight and body mass index by week 9, but no changes were observed in control subjects. Mean CD4+ count increased by 14% for patients on colostrum-based supplement, in contrast to 12% decrease in controls (p < 0.001).

Conclusions

This study shows that addition of colostrum-based supplement to standard therapy is effective in treatment of HIV-associated diarrhea.
Literatur
2.
Zurück zum Zitat MOH 2003. Ministry of Health HIV/AIDS Policy, 2003. MOH 2003. Ministry of Health HIV/AIDS Policy, 2003.
3.
Zurück zum Zitat Rump JA, Arndt R, Arnold A, et al. Treatment of diarrhea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clin Invest. 1992;70:588–94.CrossRef Rump JA, Arndt R, Arnold A, et al. Treatment of diarrhea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clin Invest. 1992;70:588–94.CrossRef
4.
Zurück zum Zitat Pakkanen R, Aalto J. Growth factors and antimicrobial factors of bovine colostrums. Int Dairy J. 1997;7:285–97.CrossRef Pakkanen R, Aalto J. Growth factors and antimicrobial factors of bovine colostrums. Int Dairy J. 1997;7:285–97.CrossRef
5.
Zurück zum Zitat Plettenberg A, Stoehr A, Stellbrink HJ, Albrecht H, Meigel W. A preparation from bovine colostrum in the treatment of HIV-positive patients with chronic diarrhea. Clin Invest. 1993;71:42–5.CrossRef Plettenberg A, Stoehr A, Stellbrink HJ, Albrecht H, Meigel W. A preparation from bovine colostrum in the treatment of HIV-positive patients with chronic diarrhea. Clin Invest. 1993;71:42–5.CrossRef
6.
Zurück zum Zitat Greenberg PD, Cello JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:348–54.PubMedCrossRef Greenberg PD, Cello JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:348–54.PubMedCrossRef
7.
Zurück zum Zitat Nord J, Ma P, DiJohn D, Tzipori S, Tacket CO. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhoea in AIDS patients. AIDS. 1990;4:581–4.PubMedCrossRef Nord J, Ma P, DiJohn D, Tzipori S, Tacket CO. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhoea in AIDS patients. AIDS. 1990;4:581–4.PubMedCrossRef
8.
Zurück zum Zitat Beth L, Ungar P, Douglas J. Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology. 1990;98:486–9. Beth L, Ungar P, Douglas J. Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology. 1990;98:486–9.
9.
Zurück zum Zitat Florén C-H, Chinenye S, Elfstrand L, Hagman C, Ihse I. ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea. Scand J Gastroenterol. 2006;41:682–6.PubMedCrossRef Florén C-H, Chinenye S, Elfstrand L, Hagman C, Ihse I. ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea. Scand J Gastroenterol. 2006;41:682–6.PubMedCrossRef
10.
Zurück zum Zitat Elfstrand L, Lindmark-Månsson H, Paulsson M, Nyberg L, Åkesson B. Immunoglobulins, growth factors and growth hormone in bovine colostrum and the effects of processing. Int Dairy J. 2002;12:879–87.CrossRef Elfstrand L, Lindmark-Månsson H, Paulsson M, Nyberg L, Åkesson B. Immunoglobulins, growth factors and growth hormone in bovine colostrum and the effects of processing. Int Dairy J. 2002;12:879–87.CrossRef
11.
Zurück zum Zitat Craig RM, Carlson S, Ehrenpreis E. Acquired immunodeficiency syndrome enteropathy: a perspective. Compr Ther. 1995;21:184–8.PubMed Craig RM, Carlson S, Ehrenpreis E. Acquired immunodeficiency syndrome enteropathy: a perspective. Compr Ther. 1995;21:184–8.PubMed
Metadaten
Titel
Effect of bovine colostrum-based food supplement in the treatment of HIV-associated diarrhea in Northern Uganda: a randomized controlled trial
verfasst von
F. O. Kaducu
S. A. Okia
G. Upenytho
L. Elfstrand
C.-H. Florén
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 6/2011
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-011-0146-0

Weitere Artikel der Ausgabe 6/2011

Indian Journal of Gastroenterology 6/2011 Zur Ausgabe

Gastroenterology Research

Gastroenterology Elsewhere

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.